POINT
PNTPOINT Biopharma Price (PNT)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
96,034,506
(30.0385)%Balance Sheet Summary
| Total Assest | |
| Total Liabilities | |
| Total Equity | |
| Total Investments | |
| Total Liabilities And Total Equ... | |
| Total debt |
Balance Sheet
POINT Biopharma Global Inc.Currency: USD
| YEAR | 2019 | 2020 | 2021 | 2022 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash And Cash Equivalents | 0.00 | 10.55M | 238.82M | 286.43M | |||||||||||||||
| Short Term Investments | 0.00 | 135.71B | 0.00 | 238.78M | |||||||||||||||
| Net Receivables | 0.00 | 58.98k | 72.67k | 60.22k | |||||||||||||||
| Inventory | 0.00 | 1.76M | 4.85M | 5.34M | |||||||||||||||
| Other Current Assets | 1.18k | 27.63k | 105.45k | 215.20k | |||||||||||||||
| Total Current Assets | 1.18k | 12.40M | 243.85M | 530.82M | |||||||||||||||
| Non Current Assets | |||||||||||||||||||
| Property, Plant, and Equipment, Net | 0.00 | 9.80M | 19.41M | 31.38M | |||||||||||||||
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Long Term Investments | 0.00 | 0.00 | 0.00 | 16.12M | |||||||||||||||
| Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Other Non-Current Assets | 0.00 | -9,797,400.00 | -19,412,086.00 | -47,500,006.00 | |||||||||||||||
| Total Non-Current Assets | 0.00 | 9.80M | 19.41M | 47.50M | |||||||||||||||
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Total Assets | 1.18k
+0% |
22.19M
+1,887,187% |
263.26M
+1,086% |
578.32M
+120% |
|||||||||||||||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Account Payables | 0.00 | 3.60M | 1.74M | 7.68M | |||||||||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Tax Payables | 0.00 | 87.88k | 250.98k | 29.70M | |||||||||||||||
| Deferred Revenue | 0.00 | 0.00 | 0.00 | 23.24M | |||||||||||||||
| Other Current Liabilities | 10.40k | 1.48M | 5.99M | 19.12M | |||||||||||||||
| Total Current Liabilities | 10.40k | 5.16M | 7.98M | 79.74M | |||||||||||||||
| Non Current Liabilities | |||||||||||||||||||
| Long Term Debt | 0.00 | 3.55M | 0.00 | 0.00 | |||||||||||||||
| Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 10.18M | |||||||||||||||
| Deferred Tax Liabilities Non-Current | 0.00 | 0.00 | 65.59k | 0.00 | |||||||||||||||
| Other Non-Current Liabilities | 0.00 | -3,550,660.00 | 0.00 | 1.45M | |||||||||||||||
| Total Non-Current Liabilities | 0.00 | 3.55M | 65.59k | 11.63M | |||||||||||||||
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Total Liabilities | 10.40k
+0% |
8.71M
+83,691% |
8.05M
-8% |
91.37M
+1,036% |
|||||||||||||||
| Equity | |||||||||||||||||||
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Common Stock | 0.00 | 5.47k | 9.01k | 10.57k | |||||||||||||||
| Retained Earnings | -9,224.00 | -13,382,227.00 | -59,284,708.00 | 39.01M | |||||||||||||||
| Accumulated Other Comprehensive Income Loss | 0.00 | 0.00 | 0.00 | -456,851.00 | |||||||||||||||
| Other Total Stockholders Equity | 0.00 | 26.86M | 314.49M | 448.39M | |||||||||||||||
| Total Stockholders Equity | -9,224.00 | 13.48M | 255.21M | 486.95M | |||||||||||||||
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Total Equity | -9,224.00
+0% |
13.48M
-146,244% |
255.21M
+1,793% |
486.95M
+91% |
|||||||||||||||
| Total Liabilities And Total Equity | 0.00
+0% |
22.19M
+0% |
263.26M
+1,086% |
578.32M
+120% |
|||||||||||||||
| Additional Metrics | |||||||||||||||||||
| Total Investments | 0.00
+0% |
135.71B
+0% |
0.00
+0% |
238.78M
+0% |
|||||||||||||||
| Total Debt | 0.00
+0% |
3.55M
+0% |
0.00
+0% |
0.00
+0% |
|||||||||||||||
| Net Debt | 0.00 | -6,996,089.00 | -238,815,991.00 | -286,428,371.00 | |||||||||||||||